Search Results 4161-4170 of 34898 for oral

  1. A Study to Evaluate the Safety and Effectiveness of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy - Mayo Clinic

    Histologically confirmed head and neck cancer (oral cavity, pharynx, larynx, sinonasal, nasopharyngeal, or unknown primary) of squamous histology not ...

  2. Mouth cancer - Doctors and departments - Mayo Clinic

    Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...

  3. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

  4. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  5. PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration - Mayo Clinic

    ... oral, intravaginal, transdermal); progestogen-only hormonal contraception (i.e., oral, injectable, implantable); intrauterine device (IUD), including ...

  6. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    HES therapy includes but is not limited to oral corticosteroid, immunosuppressive, and cytotoxic therapy. Male or female. A female subject is eligible to ...

  7. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology ... vascular surgery, Parotidectomy, Transoral laser microsurgery, Throat cancer, Oral ...

  8. Ixekizumab in the Treatment of Bullous Pemphigoid - Mayo Clinic

    Oral antibiotics and/or niacinamide. Exclusion Criteria: Subjects fulfilling any of the following criteria are not eligible for inclusion in this study. In ...

  9. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

    Oral or implanted hormonal contraceptive (e.g., Implanon™);. NOTE: For subjects in Sweden, low dose oral contraceptives are not permitted. An intra-uterine ...

  10. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Diabetic patients who are taking insulin or oral anti-diabetic therapy ... oral polio, BCG, yellow fever, varicella, and TY21a typhoid vaccines. Not ...